Value of genetic testing in the prevention of coronary heart disease events Y Hynninen et al, PLOS One, January 2019

Main|Search|PHGKB






Last Posted: Jan 20, 2019

---

• Value of genetic testing in the prevention of coronary heart disease events
  Y Hynninen et al, PLOS One, January 2019
• Why information alone is not enough: behavioral economics and the future of genomic medicine.
  Blumenthal-Barby J S et al. Annals of internal medicine 2014 Oct 161(8) 605-6
• Addressing perceived economic obstacles to genetic testing as a way to mitigate disparities in family health history for adoptees.
  May Thomas et al. Health economics, policy, and law 2018 Dec 1-11
• Estimating the burden and economic impact of pediatric genetic disease
  N Gonzaludo et al, Genetics in Medicine, December 19, 2018
• Budget Impact Analysis of Eliglustat for the Treatment of Gaucher Disease Type 1 in the United States.
  Nalysnyk Luba et al. Journal of managed care & specialty pharmacy 2018 Oct 24(10) 1002-1008
• A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults
  M. Murray and the Genomics and Population Health Action Collaborative, National Academies of Medicine, December 3, 2018
• Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer.
  Signorovitch James et al. Journal of medical economics 2018 Nov 1-27
• Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer.
  Yu Tiffany M et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2018 Nov 21(11) 1278-1285
• Amplification-free, sequence-specific 16S rRNA detection at 1 aM.
  Koo Bonhye et al. Lab on a chip 2018 07 (15) 2291-2299
• Impact of Precision Medicine on Drug Repositioning and Pricing: A Too Small to Thrive Crisis.
  Tiriveedhi Venkataswarup et al. Journal of personalized medicine 2018 Nov 8(4)

more